DE69120396D1 - Neue verwendung von linomide (r) - Google Patents

Neue verwendung von linomide (r)

Info

Publication number
DE69120396D1
DE69120396D1 DE69120396T DE69120396T DE69120396D1 DE 69120396 D1 DE69120396 D1 DE 69120396D1 DE 69120396 T DE69120396 T DE 69120396T DE 69120396 T DE69120396 T DE 69120396T DE 69120396 D1 DE69120396 D1 DE 69120396D1
Authority
DE
Germany
Prior art keywords
linomide
new use
treatment
invention concerns
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69120396T
Other languages
English (en)
Other versions
DE69120396T2 (de
Inventor
Bo Nilsson
Terje Kalland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Application granted granted Critical
Publication of DE69120396D1 publication Critical patent/DE69120396D1/de
Publication of DE69120396T2 publication Critical patent/DE69120396T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69120396T 1990-02-22 1991-02-21 Neue verwendung von linomide (r) Expired - Fee Related DE69120396T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9000624A SE9000624D0 (sv) 1990-02-22 1990-02-22 New use
PCT/SE1991/000136 WO1991012804A1 (en) 1990-02-22 1991-02-21 New use

Publications (2)

Publication Number Publication Date
DE69120396D1 true DE69120396D1 (de) 1996-07-25
DE69120396T2 DE69120396T2 (de) 1997-01-30

Family

ID=20378638

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69120396T Expired - Fee Related DE69120396T2 (de) 1990-02-22 1991-02-21 Neue verwendung von linomide (r)

Country Status (11)

Country Link
EP (1) EP0516725B1 (de)
JP (1) JPH05503532A (de)
AT (1) ATE139442T1 (de)
AU (1) AU641002B2 (de)
CA (1) CA2076650C (de)
DE (1) DE69120396T2 (de)
DK (1) DK0516725T3 (de)
ES (1) ES2089194T3 (de)
GR (1) GR3020798T3 (de)
SE (1) SE9000624D0 (de)
WO (1) WO1991012804A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9201076L (sv) * 1992-04-06 1993-10-07 Shimon Slavin Användningen av gamla läkemedel för behandling av diabetes
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
SE9400809D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of quinoline-3-carboxamide compounds
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds
IL129871A (en) 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
CN1284878A (zh) * 1997-12-15 2001-02-21 藤泽药品工业株式会社 增强nkt细胞的药物
DE60315796T2 (de) * 2002-01-17 2008-06-05 Merck & Co., Inc. Hydroxynaphthyridinoncarbonsäureamide, die sich als inhibitoren der hiv-integrase eignen
CN101094594B (zh) 2003-12-08 2012-08-15 海布里顿公司 通过基于小寡核苷酸的化合物调节免疫刺激性质

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation

Also Published As

Publication number Publication date
SE9000624D0 (sv) 1990-02-22
ATE139442T1 (de) 1996-07-15
EP0516725A1 (de) 1992-12-09
CA2076650C (en) 1998-04-28
DE69120396T2 (de) 1997-01-30
DK0516725T3 (da) 1996-09-09
AU641002B2 (en) 1993-09-09
ES2089194T3 (es) 1996-10-01
EP0516725B1 (de) 1996-06-19
GR3020798T3 (en) 1996-11-30
AU7446691A (en) 1991-09-18
WO1991012804A1 (en) 1991-09-05
CA2076650A1 (en) 1991-08-23
JPH05503532A (ja) 1993-06-10

Similar Documents

Publication Publication Date Title
ES2134764T3 (es) Inhibidores de hiv proteasa.
SE8704298D0 (sv) Compounds for use in therapy
EP0458699A3 (en) Use of baclofen for the preparation of medicaments for the treatment of angina pectoris
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
DE69120396D1 (de) Neue verwendung von linomide (r)
DK0424156T3 (da) Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser
NO891894L (no) Fremgangsmaate for fremstilling av antikoagulerende peptidalkoholer.
NO910559D0 (no) Fremgangsmaate for fremstilling av polyfosfasener ved substitusjon av polydiklorfosfasen.
FI952420A (fi) Glukopyranosidibentsotiofeenit
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
DE3874606D1 (de) Behandlung von viraler infektion.
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen
ATE164066T1 (de) Neue pharmazeutische formulierungen von 5-(2- chlor-1-hydroxyethyl)-4-methylthiazol
SE9000288D0 (sv) New use
MX9202948A (es) Uso de atipamezol.
FI934053A (fi) Antibakteriella aemnen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee